+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Influenza Vaccine Market (2022-2027) by Vaccine Type, Age Group, Administration Route, Distribution Channel, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 172 Pages
  • September 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5684290

In March 2022, the Australian Government Invested More Than USD 100 Mn in the Seasonal Influenza Vaccine to Protect the People Most at Risk

The Global Influenza Vaccine Market is estimated to be USD 7.12 Mn in 2022 and is expected to reach USD 11.11 Mn by 2027, growing at a CAGR of 9.31%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Influenza Vaccine Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Influenza Vaccine Market is segmented based on Vaccine Type, Age Group, Administration Route, Distribution Channel, and Geography.
  • By Vaccine Type, the market is classified into Inactivated, Live Attenuated and Recombinant.
  • By Age Group, the market is classified into Adolescent Vaccination, Adult Vaccination, and Infant Vaccination.
  • By Administration Route, the market is classified into Intramuscular, Intranasal, and Oral.
  • By Distribution Channel, the market is classified into Government Medical Office, Hospital & Clinic, Retail Pharmacy, and Urgent Care Unit.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Bayer AG, BioDiem, BiondVax Pharmaceuticals Ltd., Bristol-Myers Squibb Company, CanSino Biologics Inc., Gamma Vaccines Pty Ltd, GlaxoSmithKline PLC, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Influenza Vaccine Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Influenza Vaccine Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Influenza Vaccine Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Influenza Vaccine Market

What is the estimated value of the Global Influenza Vaccine Market?

The Global Influenza Vaccine Market was estimated to be valued at $7.12 Million in 2022.

What is the growth rate of the Global Influenza Vaccine Market?

The growth rate of the Global Influenza Vaccine Market is 9.3%, with an estimated value of $11.11 Million by 2027.

What is the forecasted size of the Global Influenza Vaccine Market?

The Global Influenza Vaccine Market is estimated to be worth $11.11 Million by 2027.

Who are the key companies in the Global Influenza Vaccine Market?

Key companies in the Global Influenza Vaccine Market include Abbott Laboratories, AstraZeneca PLC, Bayer AG, BioDiem, BiondVax Pharmaceuticals Ltd., Bristol, Myers Squibb Company, CanSino Biologics Inc. and Emergent BioSolutions Inc..

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Prevalence of Respiratory Disorders
4.1.2 Ongoing Clinical Trials and Vaccine Developments in Pipeline
4.1.3 Government Initiatives Supporting Respiratory Health
4.2 Restraints
4.2.1 Lack of Inadequate Delivery Infrastructure & Limited Awareness
4.3 Opportunities
4.3.1 Increasing R&D Expenditure by Leading Market Players
4.3.2 Increasing Vaccine Availability through Distribution and Development Collaborations
4.4 Challenges
4.4.1 Customers Trust and Confidence in Respiratory Disease Vaccination
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Ansoff Matrix Analysis
6 Global Influenza Vaccine Market, By Vaccine Type
6.1 Introduction
6.2 Inactivated
6.3 Live Attenuated
6.4 Recombinant
7 Global Influenza Vaccine Market, By Age Group
7.1 Introduction
7.2 Adolescent Vaccination
7.3 Adult Vaccination
7.4 Infant Vaccination
8 Global Influenza Vaccine Market, By Administration Route
8.1 Introduction
8.2 Intramuscular
8.3 Intranasal
8.4 Oral
9 Global Influenza Vaccine Market, By Distribution Channel
9.1 Introduction
9.2 Government Medical Office
9.3 Hospital & Clinic
9.4 Retail Pharmacy
9.5 Urgent Care Unit
10 Americas’ Influenza Vaccine Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas
11 Europe’s Influenza Vaccine Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Italy
11.9 Netherlands
11.10 Norway
11.11 Poland
11.12 Russia
11.13 Spain
11.14 Sweden
11.15 Switzerland
11.16 United Kingdom
11.17 Rest of Europe
12 Middle East and Africa’s Influenza Vaccine Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Qatar
12.5 Saudi Arabia
12.6 South Africa
12.7 United Arab Emirates
12.8 Rest of MEA
13 APAC’s Influenza Vaccine Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific
14 Competitive Landscape
14.1 Competitive Quadrant
14.2 Market Share Analysis
14.3 Strategic Initiatives
14.3.1 M&A and Investments
14.3.2 Partnerships and Collaborations
14.3.3 Product Developments and Improvements
15 Company Profiles
15.1 Abbott Laboratories
15.2 AstraZeneca PLC
15.3 Bayer AG
15.4 BioDiem
15.5 BiondVax Pharmaceuticals Ltd.
15.6 Bristol-Myers Squibb Company
15.7 CanSino Biologics Inc.
15.8 Daiichi Sankyo Company, Limited
15.9 Emergent BioSolutions Inc.
15.10 Eurocept Group
15.11 Fluart Innovative Vaccines Kft.
15.12 Gamma Vaccines Pty Ltd
15.13 GlaxoSmithKline PLC
15.14 Johnson & Johnson
15.15 Merck & Co., Inc.
15.16 Pfizer Inc.
15.17 Sanofi S.A.
15.18 Seqirus GmbH
15.19 Serum Institute of India Pvt. Ltd.
15.20 Sinovac Biotech Ltd.
15.21 Swedish Orphan Biovitrum AB
16 Appendix
16.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca PLC
  • Bayer AG
  • BioDiem
  • BiondVax Pharmaceuticals Ltd.
  • Bristol-Myers Squibb Company
  • CanSino Biologics Inc.
  • Daiichi Sankyo Company, Limited
  • Emergent BioSolutions Inc.
  • Eurocept Group
  • Fluart Innovative Vaccines Kft.
  • Gamma Vaccines Pty Ltd
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Seqirus GmbH
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Swedish Orphan Biovitrum AB